Aspiriant LLC’s GMO US Quality ETF QLTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,304
Closed -$284K 315
2025
Q2
$284K Hold
8,304
0.01% 264
2025
Q1
$260K Hold
8,304
0.01% 253
2024
Q4
$265K Hold
8,304
0.01% 248
2024
Q3
$271K Hold
8,304
0.01% 245
2024
Q2
$258K Buy
+8,304
New +$247K 0.01% 250

Other funds holding QLTY

Aspiriant LLC's QLTY Position: Q3 2025 in Review

Aspiriant LLC sold out of GMO US Quality ETF (QLTY) in Q3 2025, closing a stake of 8,304 shares — an estimated $284K sold.

Aspiriant LLC first reported a position in QLTY in Q2 2024 and held it in 5 quarters. The position peaked at $284K in Q2 2025. 119 funds tracked by Wall St. Rank hold QLTY as of Q3 2025.

  • Aspiriant LLC reported no remaining GMO US Quality ETF position as of Q3 2025 after selling out during the quarter.
  • Aspiriant LLC sold 8,304 GMO US Quality ETF shares in Q3 2025, an estimated $284K.
  • Aspiriant LLC first reported a position in GMO US Quality ETF in Q2 2024 and held it in 5 quarters.
  • Aspiriant LLC's GMO US Quality ETF position peaked at $284K in Q2 2025.
  • 119 funds tracked by Wall St. Rank held GMO US Quality ETF as of Q3 2025.

Based on Aspiriant LLC's 13F filing for Q3 2025, filed 24 Oct 2025.